Your browser doesn't support javascript.
loading
Assessment of the clinical and cost-effectiveness evidence in the reimbursement decisions of new cancer drugs.
Chauca Strand, G; Bonander, C; Jakobsson, N; Johansson, N; Svensson, M.
Afiliación
  • Chauca Strand G; Health Economics and Policy, School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg. Electronic address: gabriella.chauca.strand@gu.se.
  • Bonander C; Health Economics and Policy, School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg.
  • Jakobsson N; Karlstad Business School, Karlstad University Faculty of Arts and Social Sciences, Karlstads Business School, Karlstad.
  • Johansson N; Health Economics and Policy, School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg; University Health Care Research Center, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Svensson M; Health Economics and Policy, School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg; Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, Florida, USA.
ESMO Open ; 7(5): 100569, 2022 10.
Article en En | MEDLINE | ID: mdl-36037568
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Health_economic_evaluation / Health_technology_assessment / Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Health_economic_evaluation / Health_technology_assessment / Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido